July 8, 2022
Mitsubishi Tanabe Pharma will jointly promote Eli Lilly’s type 2 diabetes med tirzepatide in Japan, the companies said on July 7. The drug is currently under regulatory review in the country. Under their deal, Mitsubishi Tanabe will be responsible for...read more